What is Kura Oncology's financing cash flow?

Kura Oncology (KURA) reported financing cash flow of $69K in Q1 2026.

How has Kura Oncology's financing cash flow changed year-over-year?

Kura Oncology's financing cash flow decreased by 51.7% year-over-year, from $143K to $69K.

What is the long-term trend for Kura Oncology's financing cash flow?

Over 2 years (2022 to 2025), Kura Oncology's financing cash flow has grown at a -78.4% compound annual growth rate (CAGR), from $38.57M to $1.79M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Kura Oncology KURA Financing Cash Flow

Financing Cash Flow at other companies

Johnson & JohnsonJNJ

$530M-94.9%

AmgenAMGN

$1.44B+135%

ExelixisEXEL

-$457.11M-55.0%

Syndax PharmaceuticalsSNDX

$7.92M+751%

AbbVieABBV

$919M+173%

Corvus PharmaceuticalsCRVS

$190.75M+68,268%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$919.7M+81.6%

Enterprise value$904.89M+90.7%

P/S12.8×+3.5×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's financing cash flow?: Kura Oncology (KURA) reported financing cash flow of $69K in Q1 2026.
How has Kura Oncology's financing cash flow changed year-over-year?: Kura Oncology's financing cash flow decreased by 51.7% year-over-year, from $143K to $69K.
What is the long-term trend for Kura Oncology's financing cash flow?: Over 2 years (2022 to 2025), Kura Oncology's financing cash flow has grown at a -78.4% compound annual growth rate (CAGR), from $38.57M to $1.79M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.